Over the past ten years, CVS Health stock (NYSE: CVS) has returned $31 billion to shareholders in the form of cash through dividends and buybacks. This shareholder-focused strategy has delivered ...

CVS Health reported higher fourth-quarter and full-year revenues in 2025, driven by growth across its pharmacy, health benefits and pharmacy services businesses. Operationally, CVS highlighted the ...

CVS Health reported third-quarter earnings and revenue that blew past estimates and raised its adjusted profit outlook, as the company sees improvement in its insurance unit. The quarterly results cap ...

CVS Health is positioned for continued outperformance, with a strong turnaround driving industry-leading results and a reiterated "Buy" rating. CVS's Q3 showed 7.8% revenue growth, 47% adjusted EPS ...

CVS Health has improved its financial results this year. The company's efforts could allow it to maintain that momentum. CVS also has long-term growth potential and a strong dividend program. That ...

A month has gone by since the last earnings report for CVS Health (CVS). Shares have lost about 1.7% in that time frame, outperforming the S&P 500. Will the recent negative trend continue leading up ...